Retos actuales de la quimioterapia tras la Refractariedad al Tratamiento Hormonal en Cáncer de Mama Metastásico

18 / 24

Phase III, randomized trial of maintenance chemo vs observation in
MBC achieving disease control with 6 cycles of 1st line chemo.
Paclitaxel 175 mg/m2 q3w
plus gemcitabine 1250 mg/m2 days 1 and
Yeon Hee Park. JCO2013 KCSG-BR07-02